Published Sep 30, 2026, 10:15 AM ET · Updated a month ago · 3 sources
Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial
CNBC Markets
·
Original Report
Lilly said it plans to start Phase 3 trials on the combo regimen adding its amylin drug eloralintide to tirzepatide at the end of the year.